Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
Completed · Not applicable
Conditions studied: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Physical activity may help lessen fatigue caused by cancer in patients receiving chemotherapy. It is not yet known whether a home-based walking and resistance-band exercise program is effective in lessening fatigue. PURPOSE: This randomized phase III trial is studying how well exercise works in lessening fatigue caused by cancer in patients undergoing chemotherapy.
Key facts
- Study ID
- NCT00924651
- Run by
- Gary Morrow
- People needed
- 693
- Starts
- 2009-09-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2017-08-08
Who can join
Age: 21 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- primary diagnosis of cancer other than leukemia, with no distant metastasis
- chemotherapy naïve
- starting chemotherapy treatments for cancer and scheduled for at least 6 weeks of treatments with treatment cycles of either 2, 3 or 4 weeks. Oral chemotherapy (e.g., Xeloda) is acceptable
- Karnofsky Performance level of 70 or greater
- able to read English
You may not qualify if…
- diagnosis of leukemia
- metastatic disease
- receiving concurrent radiation therapy
- physical limitations (e.g., cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in a low to moderate intensity home-based walking and progressive resistance program
- identified as in the active or maintenance stage of exercise behavior as assessed by the Exercise Stages of Change Short Form
Where it is running
- James P. Wilmot Cancer Center at University of Rochester Medical Center — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.